SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-012373
Filing Date
2024-03-21
Accepted
2024-03-21 07:43:56
Documents
15
Period of Report
2024-03-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mlys-20240321.htm   iXBRL 8-K 30904
2 EX-99.1 mlys-fy238kex991.htm EX-99.1 69963
6 a1.jpg GRAPHIC 5244
  Complete submission text file 0001628280-24-012373.txt   250916

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mlys-20240321.xsd EX-101.SCH 1913
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mlys-20240321_lab.xml EX-101.LAB 23449
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mlys-20240321_pre.xml EX-101.PRE 13589
18 EXTRACTED XBRL INSTANCE DOCUMENT mlys-20240321_htm.xml XML 2929
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41614 | Film No.: 24769473
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)